Mebias Discovery
Latest round
- Seed
Last raised
- Mar 2016
Total raised
- Undisclosed
Investors
- 1
About Mebias Discovery
Founded in 2015 in Philadelphia, US, Mebias Discovery specializes in pharmaceutical development. The company has successfully completed 4 deals, with their most recent deal occurring on October 14, 2019.Mebias Discovery specializes in developing innovative pharmaceuticals through its proprietary membrane protein-NMR drug discovery platform, which identifies molecules that interact with G-protein coupled receptors (GPCRs). The company is advancing an Investigational New Drug for the mu-opioid receptor, currently in Phase 1 Clinical Studies, and developing Sphingosine 1-phosphate receptor agonists for neuropathic pain and neuroinflammation.Mebias Discovery's revenue model focuses on advancing proprietary drug candidates into clinical development through strategic partnerships with pharmaceutical firms. The company engages in B2B transactions and aims to generate returns via milestone payments and royalties as its products progress through clinical trials. The company is also exploring new markets in Europe and Asia, aiming for expansion by 2023. Upcoming product launches include additional GPCR-targeted therapeutics, which are expected to enhance their portfolio and market presence.
Who invested in Mebias Discovery
1 investor across 1 round
See all investors in Mebias Discovery
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 1, 2016
Amount
Undisclosed
Investors
Questions about Mebias Discovery
Who invested in Mebias Discovery?
Mebias Discovery has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mebias Discovery raised?
Mebias Discovery has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mebias Discovery last raise money?
Mebias Discovery's most recent round on record is a Seed, in Mar 2016.
What does Mebias Discovery do?
Founded in 2015 in Philadelphia, US, Mebias Discovery specializes in pharmaceutical development.
Where is Mebias Discovery headquartered?
Mebias Discovery is headquartered in Philadelphia, US.
Which VCs invest in companies like Mebias Discovery?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mebias Discovery's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mebias Discovery? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.